New video about ESCAS

Aphasia is one of the most challenging and most debilitating consequences of ischemic stroke. It affects not only a patient’s ability to communicate, but also their independence, social interactions and overall quality of life. Recovery can be slow and incomplete, making early and effective interventions critical.

The ESCAS study investigated the potential benefits of Cerebrolysin^® combined with speech and language therapy in patients with post-stroke aphasia. The results show significant improvements in language function and overall quality of life.

Watch this video to learn more about aphasia, its challenges and how Cerebrolysin^® helps patients regain independence.